Population-based BRCA1/BRCA2 screening in Ashkenazi Jews: a call for evidence

testing in the Ashkenazi Jewish population,aimed at reducing morbidity and mortality of breast/ovariancancer, is seemingly an obvious candidate for such a screeningprogram. In Ashkenazi Jews, three common, easily tested mu-tations account for the majority of deleterious alleles, effectivepreventive measures for